AUTOLOGOUS RECOMBINANT CELL THERAPY FOR MACULAR DEGENERATION? A combination of the best of two approaches; taking a patient’s own cells, adding a gene, and inserting into the patient’s eye lesion, in the hope of regrowing the damaged tissue. Brilliant solution for a tough disease. And better still: heading for clinical trials.
http://lnkd.in/JrNWzf
linkedin post 2022-06-29 05:12:48
Nigel Fleming
September 21, 2022